Efficacy News and Research

RSS

Scientists develop new method for more effective photothermal treatment of tumors

Nanorods made of bismuth sulfide kill tumor cells with heat when they are irradiated with near-infrared light. Chinese scientists are now making these weapons more powerful by remodeling the defect state of the nanorod crystal lattice by adding gold nanodots.

12 Dec 2017

Researchers identify promising solution for improving cystic fibrosis treatments

Researchers at the University of Montreal Hospital Research Centre have identified a promising solution to improving treatments offered to patients with cystic fibrosis.

12 Dec 2017

Hidden genes hold blueprints for designing new anti-cancer drugs

New research suggests these hidden genes hold the blueprints for designing new, even more effective cancer-targeting compounds.

12 Dec 2017

First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetes

The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.

12 Dec 2017

Researchers uncover novel strategy to program immune system for fighting cancer

Looking to bolster the body's immune system in the fight against infection and cancer, researchers at the University of California San Diego and their colleagues have identified a promising new strategy to program the immune system to meet the pathogen or malignancy in the tissues where they first pose a threat.

11 Dec 2017

Rice scientists develop method to identify patients at high risk of continued seizures before surgery

Surgery to remove a part of the brain to give relief to patients with epilepsy doesn't always result in complete seizure relief, but statisticians at Rice University have developed a method for integrating neuroimaging scans to identify patients at high risk of continued seizures before the surgery takes place.

11 Dec 2017

New, more easily administered therapies offer benefits for bleeding and clotting disorders

In three studies being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report remarkable benefits from new, more easily administered therapies for bleeding and clotting disorders.

11 Dec 2017

Novel compound along with checkpoint inhibitors may enhance immune response in melanoma patients

A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.

8 Dec 2017

Study finds mechanism of resistance to checkpoint inhibitors and way to reverse it

Researchers have discovered a mechanism of resistance to checkpoint inhibitors and how to reverse it. The biomarker results from the IMvigor210 study are reported at the ESMO Immuno Oncology Congress 2017.

8 Dec 2017

MIT researchers discover new way to make bacteria vulnerable to existing antibiotics

MIT researchers have discovered a way to make bacteria more vulnerable to a class of antibiotics known as quinolones, which include ciprofloxacin and are often used to treat infections such as Escherichia coli and Staphylococcus aureus.

8 Dec 2017

Taurine could boost effectiveness of existing multiple sclerosis therapies

New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies.

8 Dec 2017

Study shows safety, efficacy of cystic fibrosis drug in children between 1 to 2 years of age

Ann & Robert H. Lurie Children's Hospital of Chicago is one of the study sites in the open label Phase 3 study that showed safety and effectiveness of the cystic fibrosis drug Kalydeco (ivacaftor) in children ages 1 to 2 years.

8 Dec 2017

New first line combination therapy shows promising results in patients with advanced NSCLC

A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS), according to results of phase III IMpower150 trial presented at the ESMO Immuno Oncology Congress 2017.

7 Dec 2017

Scientists develop reversible superglue seal to treat ocular injuries

When a soldier sustains a traumatic eye injury on the battlefield, any delay in treatment may lead to permanent vision loss. With medical facilities potentially far away and no existing tools to prevent deterioration, medics are in a high-stakes race against the clock.

6 Dec 2017

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

Multiple myeloma is the second most common blood cancer in the United States. Thirty to 50 percent of multiple myeloma patients have extra copies of the gene that encodes the enzyme ADAR1.

6 Dec 2017

Penn study: New dental material kills bacteria and resists biofilm growth

Dentists rely on composite materials to perform restorative procedures, such as filling cavities. Yet these materials, like tooth enamel, can be vulnerable to the growth of plaque, the sticky biofilm that leads to tooth decay.

5 Dec 2017

New approaches show promise to fight against drug-resistant superbugs in hospitals

If you visit a doctor's surgery or hospital you may be asked to apply a hand sanitizer upon entry. Strict hand hygiene practices have become one of the most essential activities in the battle against reducing multi-drug resistant infections in hospitals, nursing homes, and other healthcare settings.

4 Dec 2017

Efficacy News and Research

Scientists develop new method for more effective photothermal treatment of tumors

Researchers identify promising solution for improving cystic fibrosis treatments

Hidden genes hold blueprints for designing new anti-cancer drugs

First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetes

Researchers uncover novel strategy to program immune system for fighting cancer

Rice scientists develop method to identify patients at high risk of continued seizures before surgery

New, more easily administered therapies offer benefits for bleeding and clotting disorders

Novel compound along with checkpoint inhibitors may enhance immune response in melanoma patients

Study finds mechanism of resistance to checkpoint inhibitors and way to reverse it

MIT researchers discover new way to make bacteria vulnerable to existing antibiotics

Taurine could boost effectiveness of existing multiple sclerosis therapies

Study shows safety, efficacy of cystic fibrosis drug in children between 1 to 2 years of age

New first line combination therapy shows promising results in patients with advanced NSCLC

Scientists develop reversible superglue seal to treat ocular injuries

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

Penn study: New dental material kills bacteria and resists biofilm growth

New approaches show promise to fight against drug-resistant superbugs in hospitals

Placenta capsules offer little to no benefit for new mothers, study shows

Altering genetic mutation could enhance FluMist vaccine’s protective effect

HPV vaccine shows long-term safety and efficacy in protecting against most virulent strains

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News